References
Evers G, Kamp M, Warneke N, Berdel W, Sabel M, Stummer W, Ewelt C (2017) 5-aminolevulinic acid-induced fluorescence in primary central nervous system lymphoma. World Neurosurg 98:375–380
Ishikawa K, Sato K, Ito T, Ozaki Y, Asanome T, Yamaguchi Y, Ishida Y, Ishizuka T, Okamura N, Fuchizaki T, Tanikawa S, Tanaka S, Nakamura H (2017) A case of tumefactive multiple sclerosis resembling malignant glioma. Jpn J Neurosurg (Tokyo) 26:688–693
Kamp MA, Fisher I, Buhner J et al (2016) 5-ALA fluorescence of cerebral metastases and its impact for the local-in-brain progression. Oncotarget 7(41):66776–66789
Miyatake S, Kuroiwa T, Kajimoto Y, Miyashita M, Tanaka H, Tsuji M (2007) Fluorescence of non-neoplastic, magnetic resonance imaging-enhancing tissue by 5-amniolevulinic acid: case report. Neurosurgery 61(5):E1101–E1104
Nestler U, Water A, Cabre P, Manzo N (2012) A case of late-onset multiple sclerosis mimicking glioblastoma and displaying intraoperative 5-aminolevulinic acid fluorescence. Acta Neurochir 154:899–901
Neuroimmunology Group of Neurology Branch of Chinese Medical Association, Neuroimmunology Committee of Chinese Society for Immunology, Immunology Society of Chinese Stroke Association (2017) Chinese guidelines for the diagnosis and management of tumefactive demyelinating lesions of central nervous system. Chin Med J 130:1838–1850
Steinmann J, Rapp M, Turowski B, Steiger HJ, Cornellius JF, Sabel M, Kamp MA (2017) 5-ALA fluorescence behavior of cerebral infectious and inflammatory disease. Neurosurg Rev 41(1):365–369
Sugita Y, Terasaki M, Shigemori M, Sakata K, Morimatsu M (2001) Acute focal demyelinating disease simulating brain tumors: histopathologic guidelines for an accurate diagnosis. Neuropathology 21:25–31
Suzuki S, Oikawa M, Ito T, Sako K, Ozaki Y, Yoshinaga T, Nishihara H, Tanaka S, Nakamura H (2008) Tumefactive multiple sclerosis: a case report. J Hokkaido Brain Res Found 12:61–64
Voellger B, Klein J, Mawrin C, Firsching R (2014) 5-aminolevulinic acid (5-ALA) fluorescence in infectious disease of the brain. Acta Neurochir 156:1977–1978
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethics standards of the Research Ethics Committee of Kurume University, and with the 1964 Helsinki declaration and its later amendments or compatible ethical standards.
Informed consent
Informed consent was obtained from the patient for publication of this manuscript.
Rights and permissions
About this article
Cite this article
Miyagi, N., Nakashima, S., Negoto, T. et al. 5-aminolevulinic acid fluorescence in tumefactive demyelinating lesion. Neurosurg Rev 41, 693–695 (2018). https://doi.org/10.1007/s10143-018-0958-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-018-0958-9